Form 4: NHI Director Jobe Exercises Options, Adjusts Holdings
Insider Transaction Report
National Health Investors Director James R. Jobe exercised stock options and adjusted his common stock holdings, increasing direct ownership.
Summary
- Director James R. Jobe exercised 25,000 stock options for National Health Investors Inc. (NHI) common stock at an exercise price of $69.20 per share on November 20, 2025.
- Concurrently, Jobe disposed of 22,135 shares of common stock at a price of $78.16 per share on the same date, likely to cover tax obligations related to the option exercise.
- Following these transactions, Jobe's direct beneficial ownership (jointly held with spouse) increased by a net of 2,865 shares, from 28,690 to 31,555 shares.
- Jobe continues to beneficially own 500 shares in an IRA SEP and 10,000 unexercised stock options with an exercise price of $73.34, expiring on March 3, 2030.
Sentiment
Score: 6
Explanation: Director exercised options, indicating confidence, but also sold shares, likely for tax purposes, which is a common practice. The net increase in direct ownership is a minor positive.
Positives
- Director James R. Jobe exercised 25,000 stock options, indicating a commitment to the company and a belief in its future value.
- The net effect of the transactions resulted in an increase of 2,865 shares in Jobe's direct beneficial ownership (jointly held with spouse) of common stock.
- The sale price of $78.16 per share was higher than the option exercise price of $69.20, reflecting a gain on the exercised options.
Negatives
- Director James R. Jobe disposed of 22,135 shares of common stock, which reduces his direct ownership, even if primarily for tax purposes.
Future Outlook
NA
Industry Context
NA
Stakeholder Impact
- Shareholders may view the director's option exercise as a positive signal of insider confidence in the company's future, although the concurrent sale of shares for tax purposes is a common and expected practice.
Key Dates
| Date | Description |
|---|---|
| 02/25/2021 | Date when 25,000 stock options became exercisable. |
| 03/03/2025 | Date when 10,000 stock options become exercisable. |
| 11/20/2025 | Transaction date for the exercise of stock options and disposition of common stock. |
| 11/24/2025 | Signature date of the reporting person. |
| 02/25/2026 | Expiration date for the 25,000 stock options that were exercised. |
| 03/03/2030 | Expiration date for the remaining 10,000 stock options. |
Recommendation
holdThe filing details a routine insider transaction where a director exercised stock options and subsequently sold a portion of the acquired shares, likely to cover taxes. This activity does not provide new fundamental information to warrant a change in investment recommendation.
Keywords
National Health Investors, NHI, Form 4, Insider Trading, Stock Options, Director Transactions, Beneficial Ownership, James R. Jobe
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.